The binding of peptide-loaded MHCII on APCs to antigen-specific T-cell receptor (TCR) and following engagement of co-stimulatory molecules CD80 (B7.1)()/CD86(B7.2) are necessary steps for T helper cells and subsequent effector CTLs activation, which are the main cells responsible for the removal of cancer cells [153]. This evidence concerns the gene CD86 and cancer.